Rankings
▼
Calendar
NVAX FY 2006 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
-$2M
-38.2% margin
Operating Income
-$25M
-525.5% margin
Net Income
-$23M
-492.6% margin
EPS (Diluted)
$-7.86
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$122M
Total Liabilities
$28M
Stockholders' Equity
$94M
Cash & Equivalents
$7M
← FY 2007
All Quarters